), double -blind EQAS  samples containing Prohibited Substance(s) and/or Metabolite(s) of Prohibited Substance(s) and/or Marker(s) of Prohibited Substance(s) or Prohibited Method(s) should be prepared from controlled administration studies  performed in human subjects .